|
|
||||||||
The Annals of Thoracic Surgery, Vol 42, 668-669, Copyright © 1986 by The Society of Thoracic Surgeons
JA Meyer
Ten consecutive patients were treated more than five years ago, for small
cell carcinoma of the lung in clinical and surgical stages I or II.
Patients underwent initial surgical resection, followed by intensive
combination chemotherapy for at least a year, or to limit of tolerance.
Four patients were classified as stage II, T2 N1; 4 had T2 N0; and 2 had T1
N0. One patient (T2 N1) died of tumor recurrence in the central nervous
system 14 months after resection. Two died of other causes before five
years, one (T2 N0) of a pulmonary embolus on the seventh postoperative day,
and the other (T2 N1) of carcinoma of the prostate at 50 months. Seven
patients (70%) remained well and disease- free at five years postoperation.
Two of the 7 died of unrelated causes, one (T2 N0) at 72 months and one (T2
N1) at 108 months. Five remain well at 61 to 112 months after resection.
Although this series is small, no reports have shown comparable survival in
a defined group of small cell carcinoma patients treated nonoperatively or
by surgical resection alone.
ARTICLES
Five-year survival in treated stage I and II small cell carcinoma of the lung
This article has been cited by other articles:
![]() |
M. Inoue, S. Miyoshi, T. Yasumitsu, T. Mori, K. Iuchi, H. Maeda, and H. Matsuda Surgical results for small cell lung cancer based on the new TNM staging system Ann. Thorac. Surg., November 1, 2000; 70(5): 1615 - 1619. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |